Stay updated with breaking news from Use Listing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bharat Biotech has sought the Drug Controller General of India's approval to conduct phase-3 trials of its intranasal vaccine (BBV154) against Covid to be used as a booster dose, sources said on Monday.
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
Hyderabad, December 20 Bharat Biotech has sought the Drug Controller General of India's approval to conduct phase-3 trials of its Covid-19 intranasal vaccine (BBV154) to use as booster dose, sources
- Nuvaxovid™ COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]) listed for emergency use by the WHO - EUL for Nuvaxovid complements listing for Novavax vaccine manufactured and marketed by Serum Institute of India as Covovax™ - EUL by WHO is a prerequisite for exports to numerous countries participating in the COVAX Facility GAITHERSBURG, Md., Dec. 21, 2021 /PRNewswire/ --...
- Nuvaxovid COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]) listed for emergency use by the WHO - EUL for Nuvaxovid complements listing for Novavax vaccine manufactured and marketed